{"organizations": [], "uuid": "46e547033689c6b05cada0971b5788f00483564b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-immunogen-says-on-jan-8-co-disclos/brief-immunogen-says-on-jan-8-co-disclosed-it-expects-to-report-that-as-of-dec-31-2017-it-had-cash-and-cash-equivalents-of-about-267-1-mln-idUSFWN1P30S5", "country": "US", "domain_rank": 408, "title": "BRIEF-Immunogen Says On Jan 8, Co Disclosed It Expects To Report That As Of Dec 31, 2017 It Had Cash And Cash Equivalents Of About $267.1 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-08T16:28:00.000+02:00", "replies_count": 0, "uuid": "46e547033689c6b05cada0971b5788f00483564b"}, "author": "", "url": "https://www.reuters.com/article/brief-immunogen-says-on-jan-8-co-disclos/brief-immunogen-says-on-jan-8-co-disclosed-it-expects-to-report-that-as-of-dec-31-2017-it-had-cash-and-cash-equivalents-of-about-267-1-mln-idUSFWN1P30S5", "ord_in_thread": 0, "title": "BRIEF-Immunogen Says On Jan 8, Co Disclosed It Expects To Report That As Of Dec 31, 2017 It Had Cash And Cash Equivalents Of About $267.1 Mln", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "sec", "sentiment": "none"}, {"name": "immunogen inc", "sentiment": "none"}, {"name": "immunogen", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "#Market News January 8, 2018 / 2:28 PM / in 13 minutes BRIEF-Immunogen Says On Jan 8, Co Disclosed It Expects To Report That As Of Dec 31, 2017 It Had Cash And Cash Equivalents Of About $267.1 Mln Reuters Staff 1 Min Read \nJan 8 (Reuters) - Immunogen Inc: \n* IMMUNOGEN SAYS ON JAN 8, CO DISCLOSED IT EXPECTS TO REPORT THAT AS OF DEC 31, 2017 IT HAD CASH AND CASH EQUIVALENTS OF ABOUT $267.1 MILLION - SEC FILING Source text ( bit.ly/2CRXR5Q ) Further company coverage:", "external_links": [], "published": "2018-01-08T16:28:00.000+02:00", "crawled": "2018-01-08T16:53:48.019+02:00", "highlightTitle": ""}